NCT06517706

Brief Summary

The aim of the experimental study is to investigate two interventions for the management of cognitive symptoms resulting from long COVID. Participants will be randomly assigned into two interventions. 1. Categorization Program (CP) training with active tDCS or 2. Categorization Program training with sham tDCS.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 24, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

November 15, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

12 months

First QC Date

July 19, 2024

Last Update Submit

December 3, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Categorization Program Test 1

    Semantic knowledge and classification behavior

    Administered pre & post training with the Categorization Program, at 6 weeks

  • Categorization Program Test 2

    Decision-Making and Rule based learning

    Administered pre & post training with the Categorization Program, at 6 weeks

  • Probe Tasks

    Decision-Making and Rule based learning

    Administered pre testing, at 2 weeks, 3 weeks and after completion of training at 6 weeks

  • WHO BREF Quality of Life

    general quality of life

    before and after training, at 6 weeks

  • Dysexecutive Questionnaire

    Test of everyday executive functioning behaviors; self and informant reports

    pre and post training, at 6 weeks

Other Outcomes (2)

  • Cognitron Cognitive Assessment Battery

    Pre & Post Testing, after completion of training at 6 weeks

  • fNIRS

    pre and post training testing, after completion of training at 6 weeks

Study Arms (2)

Control Condition

SHAM COMPARATOR

Combination of cognitive training with sham tDCS

Behavioral: Categorization Program

Experimental Condition

EXPERIMENTAL

Combination of cognitive training with active tDCS

Combination Product: Combination of tDCS (device) with cognitive training (behavioral)

Interventions

Participation in 15 one-hour sessions distributed over three weeks. During each session participants will receive two sessions of tDCS plus cognitive training with the Categorization Program

Experimental Condition

Participation in 15 one-hour sessions distributed over three weeks. During each session participants will receive cognitive training and sham tDCS

Control Condition

Eligibility Criteria

Age25 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Reported cognitive difficulties due to COVID-19 infection
  • WHO Long COVID criteria will be used

You may not qualify if:

  • Significant history of neuropsychiatric conditions prior to contracting COVID-19; history of neurological conditions such as TBI, CVA, MS prior to contracting COVID-19.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Cyprus

Nicosia, Cyprus, 1678, Cyprus

RECRUITING

Related Links

Study Officials

  • Fofi Constantinidou, Ph.D.

    University of Cyprus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fofi Constantinidou, Ph.D.

CONTACT

Eleni Michael

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants will be randomly assigned to the experimental and control group. Both groups will receive cognitive rehabilitation. The experimental group control group will also active tDCS treatment whereas the control will receive inactive or sham tDCS treatment
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: Random Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychology

Study Record Dates

First Submitted

July 19, 2024

First Posted

July 24, 2024

Study Start

November 15, 2024

Primary Completion

October 31, 2025

Study Completion

December 31, 2025

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Anonymized data will be entered in an open access depository as per funding agency's requirements. IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
After data has been published, December 2026.
Access Criteria
upon request
More information

Locations